The effect of adjuvant chemotherapy on the prognosis in the patients with familial pancreatic cancer (JON2201-P)
Not Applicable
- Conditions
- Pancreatic cancer treated with postoperative adjuvant chemotherapy
- Registration Number
- JPRN-UMIN000052109
- Lead Sponsor
- Japan Oncology Network in Hepatobiliary and Pancreas (JON-HBP)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with preoperative chemotherapy (neoadjuvant chemotherapy or neoadjuvant chemo-radiotherapy) 2. Patients who have not undergone R0 or R1 resection 3. Histological types other than pancreatic ductal cancer 4. Patients who have not been treated by postoperative adjuvant chemotherapy 5. Patients who have opted out and have been refused access to medical information by research subjects or their familiy
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postoperative recurrence-free survival period
- Secondary Outcome Measures
Name Time Method